Avertim in Life Sciences & Chemicals

SECTOR INTRODUCTION & CHALLENGES:

The Past years have seen increasing price pressures on Life Sciences & Chemicals companies, either by health authorities focusing increasingly on value of innovation for patients, increased (European) regulation for Medical Devices or in-vitro diagnostics or inflation and price increases on raw materials.

Companies in this sector must walk a fine line between - seemingly conflicting - priorities. They must embrace digitalization and emerging technologies and deliver strong results from product development pipelines to keep providing value for customers.

Finaly, regulatory pressures with new regulation on all aspects of the LS & C sector are begin implemented, such as CSDR, leading to novel ways of thinking about operating a company in a sustainable way, and require implementation of new solutions.

It is essential that companies in this sector connect strategy and operations management to steer towards success. The pressures above lead to companies needing to rethink how they manage risk, control operating costs, and define new roadmaps and ambitions

HOW AVERTIM CAN HELP THE CLIENT IN THAT SPECIFIC SECTOR:

We have been working with the leading companies that have defined the course of the industry for more than 15 years. We have developed a unique industry expertise and are able to guide you through the challenges the industry is facing today.

Digitalization & Emerging Technologies

LS&C industry needs to embrace digital and emerging technologies to stay relevant. The digital transformation within the industry is in full force. Avertim provides a full range of Digital solutions from assessment to implementation, leveraging our strengths to translate strategy towards implementation in collaboration with our clients. Among others, we can help you to:

Develop a rationale for digitalization (including maturity assessment, business case, transformation plan and global to local strategy translation)
Implement digital solutions (including digital roadmap, digital twins, control towers, QMS/LIMS/MES implementation, advanced analytics and machine learning technologies)
Ensure Successful implementation of digital solutions across the value chain (KPI tracking, Digital project & portfolio management,Digital collaboration & way of working)

Regulatory Pressure & Compliance

The Life Sciences & Chemicals industry operates under strict oversights to ensure the development, production and distribution of pharmaceutical and chemical products meet strict standards, making compliance a crucial aspect along the entire value chain. Among others, we are specialized in :

Audit & inspection readiness, incoming materials management
Quality Event Management, Quality Risk Assessment
Qualification and Validation activities
Data integrity & CSV

Moving towards a Green Industry

The Life Science & Chemicals industry is making significant progress in the journey towards becoming a sustainable and green industry. Companies are integrating sustainability into their operations and are addressing health issues such as patient safety, access to healthcare. Our expertise covers:

Life cycle Management
Sustainable Operational Excellence
CSRD reporting
...

Patient Value & Centricity

Companies are facing increased pressure to ensure that new healthcare solutions provide real patient value in a highly price sensitive market. In addition to that, the industry needs to adopt a patient-centric approach, integrate patient feedback in the development and embrace value-based healthcare principles. We can help you to:

Patient Journey Mapping & VBHV implementation
Patient & Market insights
Using Patient Reported Outcomes in Practice

Pressure on Drug Development

Companies are facing an increased pressure on successful development, acquisition and launch of new therapies, leading to an increasing pressure on their Research and development process and development pipeline in a highly competitive environment. We are experienced in:

R&D Process Optimization
Early & Late Stage Project and Portfolio Management
R&D Alliance Management
Digital R&D and Clinical Innovation

Future challenges

Regulatory and quality compliance

Set up proper risk-monitoring, quality systems and culture to leverage on compliance for better products and services

Research & Development profitability

Control spending and ensure sufficient results and payoffs to preserve revenue base in a context of increased competition and government subsidies reduction

Emerging markets and outsourcing

Increasing emerging markets demand, low-value activities outsourcing and R&D relocation to attractive countries force companies to look after flexibility and efficiency in third parties management (eg: CDMO, CRO...)